PITB is a selective and orally active transthyretin (TTR) aggregation inhibitor. PITB can be used for transthyretin amyloidosis (ATTR) disease research[1].
Molecular Weight:
307.23
Formula:
C14H10FNO6
Target:
Transthyretin (TTR)
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
